hVIVO plc (LON:HVO – Get Rating)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 11.78 ($0.14) and traded as high as GBX 15.51 ($0.19). hVIVO shares last traded at GBX 15.28 ($0.19), with a volume of 1,329,042 shares changing hands.
hVIVO Stock Up 1.0 %
The firm’s 50-day moving average price is GBX 11.78 and its 200 day moving average price is GBX 15.15. The company has a market capitalization of £102.67 million and a price-to-earnings ratio of -0.76. The company has a current ratio of 1.19, a quick ratio of 1.16 and a debt-to-equity ratio of 10.88.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
- Microsoft Layoffs Signal Layoffs for Other Tech Companies?
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.